Craig A. Johnson

Insider Reports History

Identity 1 fact
Location
Edmonton
SEC filing record 1 fact
SEC signature
/s/Kathryn Lester Attorney-in-fact for Craig A. Johnson
SEC evidence 1 fact
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Craig A. Johnson

Form 4 holding Director

HERON THERAPEUTICS, INC. /DE/

Security class
Stock Option (Right to Buy)
Shares / value
35,900
Estimated value
$62,107
Report date
31 Jan 2025
Price
$1.73
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

LA JOLLA PHARMACEUTICAL CO

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
22 Aug 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Mirati Therapeutics, Inc.

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
23 Jan 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Craig A. Johnson

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .